Drug Shortage Report for UROMITEXAN
Report ID | 51103 |
Drug Identification Number | 02371839 |
Brand name | UROMITEXAN |
Common or Proper name | Uromitexan |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | MESNA |
Strength(s) | 100MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10mL |
ATC code | V03AF |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2018-06-01 |
Actual start date | 2018-06-01 |
Estimated end date | 2018-06-21 |
Actual end date | 2018-06-21 |
Shortage status | Resolved |
Updated date | 2018-06-22 |
Company comments | Substitutes available: 2639B2019 (Uromitexan 4mL ampoule), 2639B2010 (Uromitexan 10mL ampoule) |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2018-06-22 | English | Compare |
v5 | 2018-06-21 | French | Compare |
v4 | 2018-06-21 | English | Compare |
v3 | 2018-06-02 | English | Compare |
v2 | 2018-06-01 | French | Compare |
v1 | 2018-06-01 | English | Compare |
Showing 1 to 6 of 6